New Biotechnology Businesses in Miami, FL

A biotechnology company focused on developing immune technologies to reprogram the body to remember and combat cancer.

Appears to be a business involved in producing research-grade peptides for scientific or medical purposes.

A biopharmaceutical company focused on developing safe, effective, and affordable drugs.

A biotech company specializing in biopharmaceutical research and development, founded by experienced leaders in the field.

Scholar Rock is a biopharmaceutical company headquartered in Cambridge, MA, dedicated to discovering and developing innovative medicines. The website describes its mission to create new possibilities through cutting-edge science, focusing on drug development. The LLC filing for Scholar Rock U.S. Operations, Inc. serves as the legal entity for its US operations.

A biotechnology company focused on the discovery and development of innovative medicines, particularly for conditions like muscular atrophy.

Appears to be a biotechnology company involved in sales and orders of lab products or services, as indicated by the sales/order page and contact information for placing orders.

Provides individualized biotech strategies and innovation services for project needs since 2009.

Convexia Labs appears to be a drug sourcing company, as indicated by the website's tagline 'Smarter Drug Sourcing Starts Here' and the founders email domain. The LLC was formed in Florida with principal address in Miami, and the website provides contact via founders email.

First Ascent Biomedical is a biotech startup founded in 2018, focused on personalized cancer treatment by identifying the right drug for each patient. The website lists officers Jim Foote, Dan Burruss, and Noah Berlow, matching the LLC filing, and is based in Miami, FL.

KIFFIK Biomedical, headquartered at 777 Brickell Avenue, Suite 500, Miami, FL, develops a platform for direct access to interstitial fluid (ISF) to enable real-time molecular diagnostics. The company is led by CEO George Cagna, COO Howard Peterson, and directors Mike Tudeen and Steven Reidel. News articles confirm a Series A funding round and partnerships, indicating an active operating business.